At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
Influence of the Electrical Dynamic Range (EDR) on Speech Perception, Vocabulary, and Quality of Life in Young Children
A person’s electrical dynamic range (EDR) in a cochlear implant (CI) is defined as the difference between the highest tolerable current level, without discomfort or…
CMS Announces Status on Processing Claims
The Centers for Medicare and Medicaid Services (CMS) recently provided guidance to Medicare Administrative Contractors (MACs) to process claims with dates of service of October…
Utah Advances Proposal to Deregulate Audiology Licensure
The Utah Department of Professional Licensing (DOPL), in coordination with the Office of Professional Licensing Review (OPLR), has proposed sweeping changes to audiology professional licensure….


